BBIO
BBIO
NASDAQ · Biotechnology

Bridgebio Pharma Inc

Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks
$74.29
+0.02 (+0.03%)
As of Nov 7, 9:48 PM ET ·
Analyst Consensus
Strong Buy
29
Analysts
High
Coverage
Buy 26 90%
Hold 3 10%
Sell 0 0%
Price Target
Analyst Price Target +155.8% upside
Low Target $141.92
Average Target $190.06
High Target $243.96
Current Price $74.29
Current
$74.29
Target
$190.06
$141.92 $190.06 avg $243.96
Scenario Analysis
Bear Case
$141.92
91.0%
Low target
Base Case
$190.06
+155.8%
Avg target
Bull Case
$243.96
+228.4%
High target
Risk/Reward
2.5x
Favorable
Price in Context
52-Week High
$93.42
-20.5% from high
52-Week Low
$60.55
+22.7% from low
50-Day SMA
$69.76
+6.5% vs SMA
200-Day SMA
$72.68
+2.2% vs SMA
RSI (14)
68.4
Neutral
Target vs 52W High
$190.06
+103.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 39 82% $257.58 -11.6%
AMGN
Amgen Inc
 Hold 42 43% $190.87 -58.5%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +117.3%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 82% $438.34 -19.9%
MRNA
Moderna Inc
 Hold 31 35% $149.45 -41.2%
REGN
Regeneron Pharmaceuticals
 Buy 37 70% $76.80 -91.5%
NTRA
Natera Inc
 Strong Buy 30 90% $142.91 -54.0%
RVMD
Revolution Medicines Inc
 Strong Buy 29 93% $114.11 -40.7%